Sunshine Lake Pharma plans to privatize and merge with CJ Pharma.However, with an outdated pipeline, the new entity's valuation performance will be disappointing, and thus has little investment value
What is covered in the Full Insight:
Merger Announcement
Rationale Behind the Deal
CJ Pharma's Performance and Sunshine Lake Pharma's Valuation
Analysis of Sunshine Lake Pharma’s Pipeline
Comparative Market Value Post-Merger
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
Unlock all research summaries
Follow top, independent analysts
Receive personalised alerts and emails
Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.